| | | |
ARB
| |
|---|
| | |
Total
|
(+)
|
(–)
|
p value
|
|---|
|
Age
|
(Years old)
|
68.8 ± 6.33
|
68.1 ± 6.10
|
70.1 ± 6.71
|
0.234
|
|
Gender (M to F ratio)
| |
149:111
|
95:72
|
54:39
|
0.855
|
|
Vintage of dialysis
|
(Years)
|
5.61 ± 3.25
|
5.63 ± 3.30
|
5.56 ± 3.18
|
0.939
|
|
Diabetes
| |
89
|
63
|
26
|
0.112
|
|
CAD
| |
50
|
37
|
13
|
0.109
|
|
CHF
| |
30
|
18
|
12
|
0.609
|
|
Stroke
| |
21
|
13
|
8
|
0.817
|
|
SBP at the beginning of session
|
(mmHg)
|
148.5 ± 9.40
|
153.2 ± 7.99
|
140.1 ± 10.3
|
<0.001
|
|
DBP at the beginning of session
|
(mmHg)
|
74.5 ± 5.44
|
75.6 ± 5.16
|
72.4 ± 5.81
|
0.024
|
|
BUN
|
(mg/dL)
|
63.0 ± 5.25
|
63.4 ± 5.16
|
62.5 ± 5.42
|
0.503
|
|
Kt/V
| |
0.96 ± 0.12
|
0.96 ± 0.11
|
0.96 ± 0.11
|
0.997
|
|
Alb
|
(g/dL)
|
3.63 ± 0.19
|
3.65 ± 0.17
|
3.60 ± 0.21
|
0.354
|
|
Hb
|
(g/dL)
|
10.0 ± 0.33
|
10.0 ± 0.32
|
10.1 ± 0.35
|
0.570
|
|
CRP
|
(mg/dL)
|
1.00 ± 0.99
|
0.97 ± 1.10
|
1.07 ± 0.77
|
0.701
|
|
K
|
(mEq/L)
|
5.0 ± 0.3
|
5.0 ± 0.3
|
4.9 ± 0.3
|
0.053
|
|
Ca
|
(mg/dL)
|
8.6 ± 0.3
|
8.6 ± 0.3
|
8.5 ± 0.3
|
0.096
|
|
P
|
(mg/dL)
|
5.3 ± 0.4
|
5.3 ± 0.4
|
5.3 ± 0.5
|
0.928
|
|
TC
|
(mg/dL)
|
155.4 ± 18.4
|
154.8 ± 18.0
|
156.3 ± 19.1
|
0.769
|
|
Blood glucose
|
(mg/dL)
|
123.4 ± 19.9
|
122.4 ± 19.5
|
125.3 ± 20.9
|
0.576
|
|
AF
| |
21
|
10
|
11
|
0.098
|
|
Changes of ST–T segment in ECG
| |
101
|
71
|
30
|
0.105
|
|
HCV infection
| |
18
|
10
|
8
|
0.428
|
|
ACEI
| |
20
|
12
|
8
|
0.683
|
|
ARB
| |
167
|
167
|
0
|
–
|
|
CCB
| |
186
|
139
|
47
|
<0.001
|
|
beta-B
| |
88
|
66
|
22
|
0.009
|
|
VD
| |
157
|
111
|
46
|
0.007
|
|
Weekly dose of Erythropoietin/DW
|
(U/w/kg)
|
119.7 ± 44.4
|
121.5 ± 44.5
|
116.6 ± 44.6
|
0.354
|
-
CAD coronary artery disease, CHF congestive heart failure, SBP systolic blood pressure, DBP diastolic blood pressure, BUN blood urea nitrogen, Alb albumin, Hb hemoglobin, CRP C-reactive protein, K serum potassium, Ca calcium, P phosphorus, TC total cholesterol, AF atrial fibrillation, HCV hepatitis C virus, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, CCB calcium channel blocker, beta-B beta receptor blocker, VD vitamin D3, DW dry weight
